1 completed, 1 terminated. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Coronary Atherosclerotic Disease: new trials by email Literature Review of Coronary Atherosclerotic Disease trials Research Report on Coronary Atherosclerotic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| YN001-004 in Patients With Coronary Atherosclerosis in Australia Dose 1 YN001, Dose 2 YN001, Evolocumab - Coronary Artery Disease, Coronary Atherosclerotic Disease | Phase 2 | Terminated | Beijing Inno Medicine Co., Ltd. | 3 | 2026-02-25 | 2026-09-23 |
| COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent Chrono Carbostent Carbofilm™ Coated Coronary Stent, Driver Cobalt Alloy Coronary Stent - Coronary Atherosclerotic Disease, Coronary Occlusive Diseases | Not applicable | Completed | CID - Carbostent & Implantable Devices | 205 | 2009-07-01 | 2018-05-07 |
Coronary Artery Disease (2) · Coronary Stenosis (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Cardiovascular Diseases (2) · Coronary Disease (2) · Heart Diseases (2) · Myocardial Ischemia (1) · Vascular Diseases (1)
evolocumab (1)
Beijing Inno Medicine Co., Ltd. (1) · CID - Carbostent & Implantable Devices (1)
Australia (1) · Italy (1)
Flavio Airoldi, Dr (1) · Teresa Chen, PhD (1)